A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

By Daniels Stephen   Casson Ed   Stegmann Jens-Ulrich   Oh Charles   Okamoto Akiko   Rauschkolb Christine   Upmalis David  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1551-1561

Informa Healthcare

Access to resources Recommend Favorite

Tapentadol, oxycodone or placebo for acute pain of vertebral compression fractures: a randomized Phase IIIb study

By Vorsanger Gary J   Farrell Jean   Xiang Jim   Chow Wing   Moskovitz Bruce L   Rosenthal Norman R  

Pain Management, Vol. 3, Iss. 2, 2013-03 ,pp. : 109-118

Future Medicine

Access to resources Recommend Favorite

Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 455-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 6, 2015-06 ,pp. : 451-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain

By Desjardins Paul J.   Black Peter M.   Daniels Steven   Bird Steven R.   Fitzgerald Brian J.   Petruschke Richard A.   Tershakovec Andrew   Chang David J.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1523-1537

Informa Healthcare

Access to resources Recommend Favorite